Trial Profile
A randomized, double-blind, parallel group, placebo-controlled, forced dose titration study evaluating the efficacy and safety of GW679769 and paroxetine in subjects with social anxiety disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Casopitant (Primary) ; Paroxetine (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 16 Nov 2006 Status change
- 10 Nov 2006 New trial record.